{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T20:41:37Z","timestamp":1771620097960,"version":"3.50.1"},"reference-count":35,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T00:00:00Z","timestamp":1726704000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Stiftung Pro Pferd, Switzerland","award":["2020-07"],"award-info":[{"award-number":["2020-07"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>(1) Background: Horses infected by a tick-borne encephalitis virus (TBEV) can develop clinically apparent infections. In humans, vaccination is the most effective preventive measure, while a vaccine is not available for horses. The objective of this study was to describe the immune response in horses after a TBEV vaccination with a human vaccine. (2) Materials and Methods: Seven healthy horses were randomised to a treatment or a control group in a stratified fashion based on TBEV\u2013IgG concentrations on day \u22124. The treatment group (n = 4) was intramuscularly vaccinated using an inactivated human TBEV vaccine on days 0 and 28; the control group (n = 3) did not receive an injection. A clinical examination and blood sampling were performed on day \u20134, 0, 2, 4, 6, 8, 10, 14, 28, 30, 32, 34, 36, 38, 43, 56, 84, and 373. A linear mixed model analysis was used to compare IgG and IgM concentrations, neutralising antibody (nAb) titres, leucocyte count, serum amyloid A (SAA), and fibrinogen and globulin concentrations between the groups and time points. (3) Results: The clinical examination was normal in all horses at all time points. There were no significant changes in SAA, globulin, and fibrinogen concentrations and leucocyte count between the groups or time points (all p &gt; 0.05). There was no significant increase in IgG, IgM, or nAb titres in the control group over time (all p &gt; 0.05). In the vaccination group, there was a significant increase in IgG concentration and nAb titres after the second vaccination (p &lt; 0.0001). There was no significant increase in IgM antibodies after the TBEV vaccination (all p &gt; 0.05). One horse in the vaccination group had an IgM concentration above the laboratory reference on day 10. (4) Conclusions: The human TBEV vaccine did not have side effects when used in healthy horses in this study. A significant rise in TBEV-specific IgG antibodies and nAbs after the second vaccination was observed. However, IgG and nAb titres have been shown to decrease within 1 year after vaccination. The results of this study indicate that a vaccination with a human vaccine only induces a mild rise in IgM antibodies and only in previously naive horses. With no significant changes to inflammatory parameters in the vaccinated horses, it remains unclear whether vaccination with the human vaccine leads to protective immunity.<\/jats:p>","DOI":"10.3390\/vaccines12091074","type":"journal-article","created":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T08:12:27Z","timestamp":1726733547000},"page":"1074","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Immune Response after Vaccination against Tick-Borne Encephalitis Virus (TBEV) in Horses"],"prefix":"10.3390","volume":"12","author":[{"given":"Dana","family":"K\u00e4lin","sequence":"first","affiliation":[{"name":"Clinic for Equine Internal Medicine, Vetsuisse Faculty, University of Zurich, 8057 Zurich, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Becsek","sequence":"additional","affiliation":[{"name":"Clinic for Equine Internal Medicine, Vetsuisse Faculty, University of Zurich, 8057 Zurich, Switzerland"},{"name":"Equine Internal Medicine, University Equine Clinic, University of Veterinary Medicine Vienna, 1210 Vienna, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen","family":"St\u00fcrmer","sequence":"additional","affiliation":[{"name":"Clinic for Equine Internal Medicine, Vetsuisse Faculty, University of Zurich, 8057 Zurich, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Bachofen","sequence":"additional","affiliation":[{"name":"Institute for Virology and Immunology, Department of Infectious Diseases and Pathobiology, Vetsuisse Faculty, University of Bern, 3012 Bern, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denise","family":"Siegrist","sequence":"additional","affiliation":[{"name":"Spiez Laboratory, Federal Office for Civil Protection, 3177 Spiez, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7509-5970","authenticated-orcid":false,"given":"Hulda R.","family":"Jonsdottir","sequence":"additional","affiliation":[{"name":"Spiez Laboratory, Federal Office for Civil Protection, 3177 Spiez, Switzerland"},{"name":"Department of Rheumatology, Immunology, and Allergology, Inselspital University Hospital, 3010 Bern, Switzerland"},{"name":"Department of BioMedical Research, University of Bern, 3012 Bern, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2162-6550","authenticated-orcid":false,"given":"Angelika","family":"Schoster","sequence":"additional","affiliation":[{"name":"Clinic for Equine Internal Medicine, Vetsuisse Faculty, University of Zurich, 8057 Zurich, Switzerland"},{"name":"Equine Clinic, Centre for Clinical Veterinary Medicine, Faculty of Veterinary Medicine, LMU Munich, 80539 Munich, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,9,19]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Kubinski, M., Beicht, J., Gerlach, T., Volz, A., Sutter, G., and Rimmelzwaan, G.F. (2020). Tick-Borne Encephalitis Virus: A Quest for Better Vaccines against a Virus on the Rise. Vaccines, 8.","DOI":"10.3390\/vaccines8030451"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Michelitsch, A., Wernike, K., Klaus, C., Dobler, G., and Beer, M. (2019). Exploring the Reservoir Hosts of Tick-Borne Encephalitis Virus. Viruses, 11.","DOI":"10.3390\/v11070669"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Conze, T.M., Bag\u00f3, Z., Revilla-Fern\u00e1ndez, S., Schlegel, J., Goehring, L.S., and Matiasek, K. (2021). Tick-Borne Encephalitis Virus (TBEV) Infection in Two Horses. Viruses, 13.","DOI":"10.3390\/v13091775"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.vetmic.2012.12.041","article-title":"Tick-borne encephalitis virus (TBEV) infection in horses: Clinical and laboratory findings and epidemiological investigations","volume":"163","author":"Klaus","year":"2013","journal-title":"Vet. Microbiol."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Fouch\u00e9, N., Oesch, S., Ziegler, U., and Gerber, V. (2021). Clinical Presentation and Laboratory Diagnostic Work-Up of a Horse with Tick-Borne Encephalitis in Switzerland. Viruses, 13.","DOI":"10.3390\/v13081474"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1089\/vbz.2017.2216","article-title":"A Serosurvey of Flavivirus Infection in Horses and Birds in Slovakia","volume":"18","author":"Csank","year":"2018","journal-title":"Vector Borne Zoonotic Dis."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"de Heus, P., Kolodziejek, J., Hub\u00e1lek, Z., Dimmel, K., Racher, V., Nowotny, N., and Cavalleri, J.V. (2021). West Nile Virus and Tick-Borne Encephalitis Virus Are Endemic in Equids in Eastern Austria. Viruses, 13.","DOI":"10.3390\/v13091873"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Gothe, L.M.R., Ganzenberg, S., Ziegler, U., Obiegala, A., Lohmann, K.L., Sieg, M., Vahlenkamp, T.W., Groschup, M.H., H\u00f6r\u00fcgel, U., and Pfeffer, M. (2023). Horses as Sentinels for the Circulation of Flaviviruses in Eastern-Central Germany. Viruses, 15.","DOI":"10.3390\/v15051108"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"17-00838","DOI":"10.2807\/1560-7917.ES.2018.23.3.17-00838","article-title":"Distinction between serological responses following tick-borne encephalitis virus (TBEV) infection vs vaccination, Sweden 2017","volume":"23","author":"Albinsson","year":"2018","journal-title":"Euro Surveill."},{"key":"ref_10","first-page":"1701","article-title":"Specific detection and differentiation of tick-borne encephalitis and West Nile virus induced IgG antibodies in humans and horses","volume":"66","author":"Rockstroh","year":"2019","journal-title":"Transbound. Emerg. Dis."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1111\/tbed.12569","article-title":"A Serological Protein Microarray for Detection of Multiple Cross-Reactive Flavivirus Infections in Horses for Veterinary and Public Health Surveillance","volume":"64","author":"Cleton","year":"2017","journal-title":"Transbound. Emerg. Dis."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1111\/jvim.16533","article-title":"Neurological disease suspected to be caused by tick-borne encephalitis virus infection in 6 horses in Switzerland","volume":"36","author":"Magouras","year":"2022","journal-title":"J. Vet. Intern. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0264-410X(92)90003-3","article-title":"A randomized phase II study of a new tick-borne encephalitis vaccine using three different doses and two immunization regimens","volume":"10","author":"Harabacz","year":"1992","journal-title":"Vaccine"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/j.vaccine.2006.10.028","article-title":"Tick-borne encephalitis (TBE) vaccination: Applying the most suitable vaccination schedule","volume":"25","author":"Beran","year":"2007","journal-title":"Vaccine"},{"key":"ref_15","first-page":"443","article-title":"Evaluation of serological tests for detecting tick-borne encephalitis virus (TBEV) antibodies in animals","volume":"124","author":"Klaus","year":"2011","journal-title":"Berl. Munch. Tierarztl. Wochenschr."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Kohler, P., Jonsdottir, H.R., Risch, L., Vernazza, P., Ackermann-Gaumann, R., and Kahlert, C.R. (2021). No neutralizing effect of pre-existing tick-borne encephalitis virus antibodies against severe acute respiratory syndrome coronavirus-2: A prospective healthcare worker study. Sci. Rep., 11.","DOI":"10.1038\/s41598-021-03685-y"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.ttbdis.2018.03.031","article-title":"Comparison of three commercial IgG and IgM ELISA kits for the detection of tick-borne encephalitis virus antibodies","volume":"9","author":"Tritten","year":"2018","journal-title":"Ticks Tick. Borne Dis."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Namekar, M., Kumar, M., O\u2019Connell, M., and Nerurkar, V.R. (2012). Effect of serum heat-inactivation and dilution on detection of anti-WNV antibodies in mice by West Nile virus E-protein microsphere immunoassay. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0045851"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"103755","DOI":"10.1016\/j.jevs.2021.103755","article-title":"Correlation Between Serum Amyloid A and Antibody Response to West Nile Virus Vaccine Antigen in Healthy Horses","volume":"106","author":"Skipper","year":"2021","journal-title":"J. Equine Vet. Sci."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0264-410X(03)00563-2","article-title":"Randomized, phase II dose-finding studies of a modified tick-borne encephalitis vaccine: Evaluation of safety and immunogenicity","volume":"22","author":"Ehrlich","year":"2003","journal-title":"Vaccine"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"5256","DOI":"10.1016\/j.vaccine.2006.03.061","article-title":"Safety and immunogenicity of the modified adult tick-borne encephalitis vaccine FSME-IMMUN: Results of two large phase 3 clinical studies","volume":"24","author":"Konior","year":"2006","journal-title":"Vaccine"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"103165","DOI":"10.1016\/j.jevs.2020.103165","article-title":"Serum Amyloid A (SAA) Concentration after Vaccination in Horses and Mules","volume":"92","author":"Duran","year":"2020","journal-title":"J. Equine Vet. Sci."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1159\/000324023","article-title":"Experimental infection of goats with tick-borne encephalitis virus and the possibilities to prevent virus transmission by raw goat milk","volume":"55","author":"Balogh","year":"2012","journal-title":"Intervirology"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Klaus, C., Ziegler, U., Hoffmann, D., Press, F., Fast, C., and Beer, M. (2019). Tick-borne encephalitis virus (TBEV) antibodies in animal sera\u2014Occurrence in goat flocks in Germany, longevity and ability to recall immunological information after more than six years. BMC Vet. Res., 15.","DOI":"10.1186\/s12917-019-2157-5"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S0264-410X(98)80102-3","article-title":"Vaccination against tick-borne encephalitis virus, a flavivirus, prevents disease but not infection, although viremia is undetectable","volume":"16","author":"Kreil","year":"1998","journal-title":"Vaccine"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.1016\/j.vaccine.2019.03.032","article-title":"Seropersistence and booster response following vaccination with FSME-IMMUN in children, adolescents, and young adults","volume":"37","author":"Poellabauer","year":"2019","journal-title":"Vaccine"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Klaus, C., Ziegler, U., Kalthoff, D., Hoffmann, B., and Beer, M. (2014). Tick-borne encephalitis virus (TBEV)\u2014findings on cross reactivity and longevity of TBEV antibodies in animal sera. BMC Vet. Res., 10.","DOI":"10.1186\/1746-6148-10-78"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.vaccine.2006.07.026","article-title":"Study of the serological response after vaccination against tick-borne encephalitis in Sweden","volume":"25","author":"Vene","year":"2007","journal-title":"Vaccine"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/jmv.1890190109","article-title":"Different immune responses after intradermal and intramuscular administration of vaccine against tick-borne encephalitis virus","volume":"19","author":"Zoulek","year":"1986","journal-title":"J. Med. Virol."},{"key":"ref_30","first-page":"73","article-title":"Immunological response in horses following West Nile virus vaccination with inactivated or recombinant vaccine","volume":"55","author":"Monaco","year":"2019","journal-title":"Vet. Ital."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vetimm.2016.10.015","article-title":"Comparison of assays for the detection of West Nile virus antibodies in equine serum after natural infection or vaccination","volume":"183","author":"Bakonyi","year":"2017","journal-title":"Vet. Immunol. Immunopathol."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Springer, A., Glass, A., Topp, A.K., and Strube, C. (2020). Zoonotic Tick-Borne Pathogens in Temperate and Cold Regions of Europe-A Review on the Prevalence in Domestic Animals. Front. Vet. Sci., 7.","DOI":"10.3389\/fvets.2020.604910"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.tvjl.2011.01.019","article-title":"Vaccination elicits a prominent acute phase response in horses","volume":"191","author":"Andersen","year":"2012","journal-title":"Vet. J."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Biondi, V., Landi, A., Pugliese, M., Merola, G., and Passantino, A. (2022). Inflammatory Response and Electrocardiographic Examination in Horses Vaccinated against Equine Herpesvirus (Ehv-1). Animals, 12.","DOI":"10.3390\/ani12060778"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Arfuso, F., Giudice, E., Di Pietro, S., Piccione, G., and Giannetto, C. (2021). Modulation of Serum Protein Electrophoretic Pattern and Leukocyte Population in Horses Vaccinated against West Nile Virus. Animals, 11.","DOI":"10.3390\/ani11020477"}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/12\/9\/1074\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:59:34Z","timestamp":1760111974000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/12\/9\/1074"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,19]]},"references-count":35,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2024,9]]}},"alternative-id":["vaccines12091074"],"URL":"https:\/\/doi.org\/10.3390\/vaccines12091074","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,19]]}}}